Ιlias Papanikolaou

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Evdoxia Kyriazopoulou, Haralampos Milionis, Symeon Metallidis et al. · Nature Medicine · 2021 · 539 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

An open label trial of anakinra to prevent respiratory failure in COVID-19

Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis et al. · eLife · 2021 · 192 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection

Charalambos Gogos, Antigone Kotsaki, George Giannikopoulos et al. · Critical Care · 2010 · 136 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +10

ACTIVATE-2: A Double-Blind Randomized Trial of BCG Vaccination Against COVID-19 in Individuals at Risk

Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki et al. · Frontiers in Immunology · 2022 · 90 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe

Τheodoros Karampitsakos, Paolo Spagnolo, Nesrin Moğulkoç et al. · Respirology · 2022 · 73 citations

Medicine, Oncology, Clinical Epidemiology +11